Innovation Pharmaceuticals Inc (IPIX)

[Justfactsmam]

HereToday as you stated...from the 10Q

"Given the safety and efficacy data already known about Brilacidin from multiple routes of administration, a Phase 2 study with Brilacidin (as intravenous solution) is in planning."

...IMO...you are "spot on" in recognizing the significance of that sentence!

Since Brilacidin has passed multiple Phase 1 (safety trials)...the language confirms Brilacidi will be skipping Phase I and will be going directly and straight to Phase II Covid-19 trials (upon positive notification of second test)

What is more revealing is the reference to the method of dosing, i.e. IV, where there is extensive dosage strength data. That would expedite the Human Trial, since body doing the clinical trials would have for method (IV) and dosage necessary to commence Human Trials without the necessity of time to decide the method and dosage efficacy of Brilacidin.

Indicating method "IV"...tells me they are pretty much along the way to documenting Brilacidin's utility against Covid-19...and will be off and running when IPIX is matched up with Grant $ and likely BP partner.

Also in mentioning "IV" discussions had to have taken place...on method.

ALSO REMEMBER... the trials on Brilacidin IV was ONE DOSAGE for it to be effective...BRILACIDIN could be the shortest HUMAN TRIAL of all the Covid-19 Therapeutic Candidate...IMHO...no more than 1 week when they realize the results...in days.

Foolish to give shares away now! (ps. whoever it was, thanks for the 182,000 shares in the low .13's)